Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 67 (1) , 63-66
- https://doi.org/10.1016/0002-9149(91)90101-p
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.Hypertension, 1989
- Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hopeJournal of the American College of Cardiology, 1988
- Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitorsThe American Journal of Medicine, 1988
- Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs.Hypertension, 1987
- The Neurohumoral Axis in Congestive Heart FailureAnnals of Internal Medicine, 1984
- Estimation of angiotensin II receptor activity in chronic congestive heart failureAmerican Heart Journal, 1984
- REDUCTION OF BLOOD PRESSURE IN MAN WITH H-142, A POTENT NEW RENIN INHIBITORThe Lancet, 1983
- Potent new inhibitors of human reninNature, 1982
- Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.Hypertension, 1981
- Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril.Hypertension, 1981